Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Research & Development: 2020-2023

Historic Research & Development for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $41.6 million.

  • Immuneering's Research & Development rose 20.65% to $11.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $41.6 million, marking a year-over-year increase of 14.75%. This contributed to the annual value of $41.6 million for FY2023, which is 14.77% up from last year.
  • Immuneering's Research & Development amounted to $41.6 million in FY2023, which was up 14.77% from $36.3 million recorded in FY2022.
  • Immuneering's 5-year Research & Development high stood at $41.6 million for FY2023, and its period low was $15.0 million during FY2020.
  • Moreover, its 3-year median value for Research & Development was $36.3 million (2022), whereas its average is $34.8 million.
  • Data for Immuneering's Research & Development shows a peak YoY surged of 76.90% (in 2021) over the last 5 years.
  • Immuneering's Research & Development (Yearly) stood at $15.0 million in 2020, then surged by 76.90% to $26.5 million in 2021, then spiked by 36.65% to $36.3 million in 2022, then climbed by 14.77% to $41.6 million in 2023.